Join to view full profile
330 Brookline AveBoston, MA 02215
Phone+1 617-754-1204
Dr. Flaumenhaft is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1997- Tufts Medical CenterResidency, Internal Medicine, 1993 - 1995
New York University School of MedicineClass of 1993
Certifications & Licensure
MA State Medical License 1999 - 2028
FL State Medical License 2017 - 2019
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Quality Data Center, Massachusetts eHealth Collaborative (MAeHC), 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing.David A Barrios, Shihui Guo, Matthew Powers, Secil Koseoglu, Sabrina Zerbey
Blood. 2026-07-23 - 1 citationsOxidized PDI promotes thrombus formation in oxidative stress.Moua Yang, Osamede C Owegie, Anika Patel, Quinn P Kennedy, James T Flaumenhaft
Blood. 2026-07-16 - Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activation.Dimitra Karagkouni, Marisa A Brake, Rushad Patell, Anna Falanga, Marina Marchetti
Science Translational Medicine. 2026-06-17
Abstracts/Posters
- The Effects of Antiplatelet Agents on EndocytosisRobert C. Flaumenhaft, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Effects of Antiplatelet Agents on EndocytosisRobert C. Flaumenhaft, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Portable Clotting Agent Slows Internal Bleeding by 97% in MiceJuly 31st, 2020- PlateletDiagnostics Develops Novel Immune-Based Platelet Function Assay to Monitor Antiplatelet TherapyApril 9th, 2026
- New Test Tells Doctors Whether Blood Thinners Are Actually WorkingApril 11th, 2026
Grant Support
- Isoquercetin as a PDI inhibitor: dose-optimization and patient phenotypingSLOAN-KETTERING INST CAN RESEARCH2025–2030
- Program in Blood Coagulation and Vascular BiologyBETH ISRAEL DEACONESS MEDICAL CENTER1999–2029
- Thiol Isomerases and Oxidant Stress in Thrombus FormationBETH ISRAEL DEACONESS MEDICAL CENTER2024–2028
- Identification Of Small Molecule Inhibitors Of Protein Disulfide IsomeraseNational Institute On Drug Abuse2011–2012
- Chemical Genetic Analysis Of Platelet Granule SecretionNational Institute On Drug Abuse2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
